IMU is a discovery engine mapping the immune system to advance precision medicine.
IMU Biosciences has raised $38.4M in total funding. The most recent round was Series A. The last funding was announced in June 2026.
IMU Biosciences's investors include British Business Bank, IQ Capital, Life Extension Ventures, Molten Ventures, COREangels.
IMU Biosciences is headquartered in London, United Kingdom.
IMU is a discovery engine mapping the immune system to advance precision medicine.
IMU Biosciences is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"IMU Biosciences — Funding & Investors." VCBacked, June 1, 2026, https://www.vcbacked.co/company/imu-biosciences. Accessed October 28, 2026.
VCBacked. (2026). IMU Biosciences — Funding & Investors. Retrieved October 28, 2026, from https://www.vcbacked.co/company/imu-biosciences
{{cite web |title=IMU Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/imu-biosciences |website=VCBacked |access-date=October 28, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated